Physician profile
Stuart Schneiderman
NPI 1952300816
$662.05
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $70.34 · 2021: $235 · 2022: $19.55 · 2024: $21.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $110.72 | 2021 | |
| Si-Bone, INC. | $105.94 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $73.09 | 2019-2020 | |
| Lilly USA, LLC | $64.52 | 2019-2021 | |
| Eisai INC. | $56.33 | 2021-2022 | |
| Assertio Therapeutics, INC. | $51.49 | 2019 | |
| Almatica Pharma LLC | $34.73 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $31.08 | 2021 | |
| Kaleo, INC. | $30.46 | 2019 | |
| Amgen INC. | $23.92 | 2020 | |
| Medline Industries LP | $23.76 | 2019 | |
| Pacira Therapeutics, INC. | $23.26 | 2019 | |
| Stryker Corporation | $21.73 | 2024 | Procedural Oxygen Mask |
| Teva Pharmaceuticals USA, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Schneiderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.